I know it is confusing because of the incredibly poor management of this company. Essentially there are two companies that own the right to sell QCide the natural variant of the product and that is BGT and STK who they gave the rights to in exchange for paying for QCide to go through the approval process. So they both have the right to sell products around teh world for QCide. For Flavocide the manufactured version BGT own the rights exclusively.
They do lots of deals with other companies to create products for teh future. I do not know what Clarke have developed so far but they do not own the rights. None of these products will come to market till 2028 and are pending whether teh product gets through the approval process or not.
So they have three years more of losses and raises before they earn any real income. i.e. No rush to buy
Add to My Watchlist
What is My Watchlist?
